Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Xing, Changsheng ^a,b   Fu, Xiaoying ^b,c   Sun, Xiaodong ^b   Guo, Peng ^b   Li, Mei ^b   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; KRUPPEL LIKE FACTOR 5; PROBASIN; KLF5 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LEVEL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CRE GENE; EPITHELIUM CELL; GENE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KRUPPEL LIKE FACTOR 5 GENE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ACETYLATION; ANIMAL; CELL LINE; CELL TRANSFORMATION; GENE INACTIVATION; GENETIC ENGINEERING; GENETICS; METABOLISM; MOLECULAR CLONING; MULTICELLULAR SPHEROID; ORCHIECTOMY; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROTEIN PROCESSING; PROTEIN TRANSPORT; TRANSGENIC MOUSE;

MUS;

ACETYLATION; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; EPITHELIAL CELLS; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; GENETIC ENGINEERING; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, TRANSGENIC; ORCHIECTOMY; ORGAN SIZE; PROSTATE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SPHEROIDS, CELLULAR;

EID: 84878749367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065538     Document Type: Article

References (56)

1. Sogawa K, Imataka H, Yamasaki Y, Kusume H, Abe H, et al. (1993) cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res 21: 1527-1532.
2. Dong JT, Chen C, (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cellular and Molecular Life Sciences 66: 2691-2706.
3. Turner J, Crossley M, (1999) Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends in Biochemical Sciences 24: 236-240.
4. Dang DT, Pevsner J, Yang VW, (2000) The biology of the mammalian Kruppel-like family of transcription factors. International Journal of Biochemistry and Cell Biology 32: 1103-1121.
5. Adam PJ, Regan CP, Hautmann MB, Owens GK, (2000) Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275: 37798-37806.
6. Chen C, Benjamin MS, Sun X, Otto KB, Guo P, et al. (2006) KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer 118: 1346-1355.
7. Zhao Y, Hamza MS, Leong HS, Lim CB, Pan YF, et al. (2008) Kruppel-like factor 5 modulates p53-independent apoptosis through Pim1 survival kinase in cancer cells. Oncogene 27: 1-8.
8. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, et al. (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nature Medicine 8: 856-863.
9. McConnell BB, Ghaleb AM, Nandan MO, Yang VW, (2007) The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29: 549-557.
10. Chen C, Bhalala HV, Qiao H, Dong JT, (2002) A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21: 6567-6572.
11. Chen C, Bhalala HV, Vessella RL, Dong JT, (2003) KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55: 81-88.
12. Yang Y, Goldstein BG, Chao HH, Katz JP, (2005) KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther 4: 1216-1221.
13. Guo P, Dong XY, Zhang X, Zhao KW, Sun X, et al. (2009) Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. Journal of Biological Chemistry 284: 6071-6078.
14. Guo P, Zhao KW, Dong XY, Sun X, Dong JT, (2009) Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J Biol Chem 284: 18184-18193.
15. Dong JT, (2001) Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 20: 173-193.
16. Nakajima Y, Akaogi K, Suzuki T, Osakabe A, Yamaguchi C, et al. (2011) Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Sci Signal 4: ra22.
17. Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, et al. (2009) Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol 23: 1385-1396.
18. Wu X, Wu J, Huang J, Powell WC, Zhang J, et al. (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101: 61-69.
19. Sun X, Fu X, Li J, Xing C, Martin DW, et al. (2012) Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality. Genesis. 2012 Nov 50(11): 819-27.
20. Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, et al. (2002) Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 161: 727-735.
21. Tyson DR, Inokuchi J, Tsunoda T, Lau A, Ornstein DK, (2007) Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium. Prostate 67: 1601-1613.
22. Guo P, Dong XY, Zhao K, Sun X, Li Q, et al. (2009) Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta. J Biol Chem 284: 28243-28252.
23. Zhao KW, Sikriwal D, Dong X, Guo P, Sun X, et al. (2011) Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells. Biochemical Journal 437: 323-333.
24. Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, et al. (2005) Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene 24: 3319-3327.
25. Webber MM, Bello D, Kleinman HK, Hoffman MP, (1997) Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18: 1225-1231.
26. Lang SH, Smith J, Hyde C, Macintosh C, Stower M, et al. (2006) Differentiation of prostate epithelial cell cultures by matrigel/stromal cell glandular reconstruction. In Vitro Cellular and Developmental Biology Animal 42: 273-280.
27. Valkenburg KC, Williams BO, (2011) Mouse models of prostate cancer. Prostate Cancer 2011: 895238.
28. Waymouth C, Coman DR, Ward-Bailey PF, (1983) Spontaneous tumors of the prostate gland in inbred strains of mice. Journal of the National Cancer Institute 70: 199-208.
29. van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA, (2001) Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195: 563-570.
30. Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, et al. (2006) Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res 66: 8598-8607.
31. Wang XD, Reeves K, Luo FR, Xu LA, Lee F, et al. (2007) Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome Biol 8: R255.
32. Pascal LE, Vencio RZ, Vessella RL, Ware CB, Vencio EF, et al. (2011) Lineage relationship of prostate cancer cell types based on gene expression. BMC Med Genomics 4: 46.
33. Parisi S, Russo T, (2011) Regulatory role of Klf5 in early mouse development and in embryonic stem cells. Vitam Horm 87: 381-397.
34. Parisi S, Passaro F, Aloia L, Manabe I, Nagai R, et al. (2008) Klf5 is involved in self-renewal of mouse embryonic stem cells. J Cell Sci 121: 2629-2634.
35. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, et al. (2008) A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10: 353-360.
36. Sur I, Rozell B, Jaks V, Bergstrom A, Toftgard R, (2006) Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis. J Cell Sci 119: 3593-3601.
37. Oldridge EE, Pellacani D, Collins AT, Maitland NJ, (2012) Prostate cancer stem cells: are they androgen-responsive? Molecular and Cellular Endocrinology 360: 14-24.
38. Bell SM, Zhang L, Mendell A, Xu Y, Haitchi HM, et al. (2011) Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. Developmental Biology 358: 79-90.
39. McConnell BB, Kim SS, Yu K, Ghaleb AM, Takeda N, et al. (2011) Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology. 2011 Oct;141(4): 1302-13, 1313.e1-6.
40. Bell SM, Zhang L, Xu Y, Besnard V, Wert SE, et al. (2012) Kruppel-like factor 5 controls villus formation and initiation of cytodifferentiation in the embryonic intestinal epithelium. Developmental Biology. 2013 Mar 15 375(2): 128-39.
41. Wan H, Luo F, Wert SE, Zhang L, Xu Y, et al. (2008) Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development 135: 2563-2572.
42. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, et al. (2005) Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metabolism 1: 27-39.
43. Shen MM, Wang X, Economides KD, Walker D, Abate-Shen C, (2008) Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harbor Symposia on Quantitative Biology 73: 529-538.
44. Salm SN, Burger PE, Coetzee S, Goto K, Moscatelli D, et al. (2005) TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol 170: 81-90.
45. Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, et al. (2009) Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation 77: 95-102.
46. Hudson DL, (2003) Prostate epithelial stem cell culture. Cytotechnology 41: 189-196.
47. Lang SH, Sharrard RM, Stark M, Villette JM, Maitland NJ, (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. British Journal of Cancer 85: 590-599.
48. English HF, Santen RJ, Isaacs JT, (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11: 229-242.
49. Harris WP, Mostaghel EA, Nelson PS, Montgomery B, (2009) Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nature Clinical Practice Urology 6: 76-85.
50. Zhu N, Gu L, Findley HW, Chen C, Dong JT, et al. (2006) KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J Biol Chem 281: 14711-14718.
51. Chen C, Sun X, Guo P, Dong XY, Sethi P, et al. (2005) Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. Journal of Biological Chemistry 280: 41553-41561.
52. Chen C, Brabham WW, Stultz BG, Frierson HF Jr, Barrett JC, et al. (2001) Defining a common region of deletion at 13q21 in human cancers. Genes, Chromosomes and Cancer 31: 333-344.
53. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rifai W, et al. (1999) DNA copy number losses in human neoplasms. American Journal of Pathology 155: 683-694.
54. Nandan MO, Yoon HS, Zhao W, Ouko LA, Chanchevalap S, et al. (2004) Kruppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 23: 3404-3413.
55. Nandan MO, McConnell BB, Ghaleb AM, Bialkowska AB, Sheng H, et al. (2008) Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 134: 120-130.
56. Nandan MO, Ghaleb AM, McConnell BB, Patel NV, Robine S, et al. (2010) Kruppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Molecular Cancer 9: 63.